This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance.

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

This report presents spending information for treatment of mental illness, substance use disorders, or both for people only enrolled in Medicaid, and those enrolled in both Medicaid and Medicare. The report also covers fee-for-service spending and managed care spending.

This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland.

This fact sheet answers common questions for behavioral health treatment and service providers about the International Classification of Diseases, 10th Edition (ICD-10) code sets.

This report examines the prevalence of mental illness, substance use disorders, or both among youth living in foster care who are covered under Medicaid. It describes the use of health services, and discusses trends across three ages groups.

This white paper report identifies and proposes strategies to address Medicaid and other reimbursement policies that may pose barriers to mental health services in primary care settings. It presents findings, discussion by an expert panel, and recommended action steps.